The expansion of the sterile filtration market will be driven by increased public and private spending on drug development and processes, methods and technologies to test the quality and reliability of all drugs. North America is the most important sterile filtration market in the world, with a market share of 46% in 2022.
NEWARK, March 9, 2023 (GLOBE NEWSWIRE) — Brainy Insights estimates that the sterile filtration market, which was $6.11 billion in 2022, will reach $15.04 billion by 2032. The need for rigorous testing and quality control in the pharmaceutical industry highlights recent news reports questioning the quality of cough syrups manufactured in India, leading to the death of children from acute kidney failure who took these products. There have been several product recalls due to the undetected death of these drugs during the testing and approval process. Lack of adequate validation of biological processes can lead to preventable death. This drains the brand’s resources and damages its reputation. Organizations and governments in other countries are equally confused. Growth in the global sterile filtration market will be driven by a renewed push for precise, sophisticated, practical and reliable quality control of pharmaceuticals. In addition, the growing demand for food, beverage and water treatment products such as reverse osmosis systems will drive the growth of the global sterile filtration market.
Download sample report (over 230 PDF pages of information): https://www.thebrainyinsights.com/enquiry/sample-request/13337
North America is home to some well-known biotech and pharmaceutical companies. Some acute and chronic health problems are becoming more prevalent in the region due to the large population, providing lucrative market prospects for pharmaceutical players to expand their product range. A strong regulatory framework governing the implementation of quality control, inspections and approvals, such as the US FDA, is favorable for market growth in the region (Food and Drug Administration). The pharmaceutical, biotechnology and research industries are investing more in research and development, which is driving the growth of the market.
The cartridge filter segment will dominate the market with the largest market share of 38% and market revenue of $2.32 billion in 2022.
The product type is divided into angioplasty balloons, capsule filters, membranes, bottle filter systems, desktop filter systems, cartridge filters, syringe filters, accessories and others. In 2022, the cartridge filter segment will dominate the market with the largest market share of 38% and $2.32 billion in market revenue.
In 2022, the pharmaceutical enterprise sector will dominate the market with the largest market share of 37% and market revenue of 2.26 billion yuan.
End users are categorized into pharmaceutical companies, food and beverage companies, academic institutions, research laboratories, biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and others. In 2022, the pharmaceutical enterprise sector will dominate the market with the largest market share of 37% and market revenue of 2.26 billion yuan.
The bioprocess segment will dominate the market with the largest market share of 39% and revenue of US$2.38 billion by 2022.
Applications are divided into filling process, buffer filtration, cell culture medium preparation, bioprocessing, water purification, air filtration, etc. The bioprocess segment will dominate the market with the highest market share of 39% and market revenue of $2.38 billion USA by 2022.
In 2022, the polyethersulfone (PES) segment will dominate the market with the largest market share of 44% and market revenue of US$2.68 billion.
Membrane types are divided into polyethersulfone (PES), nylon, mixed cellulose ether, polyvinylidene fluoride (PVF), polytetrafluoroethylene (PTFE), cellulose acetate, etc. In 2022, the polyethersulfone (PES) segment will dominate the market with the largest market share of 44 % and market revenue of $2.68 billion.
February 2023 – Parker Bioscience Filtration has developed the Valairdata 4 portable filter testing system to reduce the potential for airborne contamination of food and beverages. This technology has created a fully automated aerosol integrity test facility that provides fast and accurate filter integrity testing, allowing operators to quickly identify any filter failures without interfering with aseptic processes. With a long battery life, the new filter testing solution is small, lightweight and portable. It has an ergonomic design with a handle that folds out during testing for quick access to the connection ports. In addition, it comes with a multilingual menu and a carrying bag.
Driving forces: Growing need for drug development due to the increasing prevalence of chronic diseases worldwide.
Changes in lifestyle and climatic conditions lead to an increase in the prevalence of chronic diseases such as cardiovascular, respiratory and neurodegenerative diseases. With the rise in incidence, the healthcare industry has made great strides in promoting the development of life-saving and other medicines. However, as drug development programs improve and manufacturing capabilities improve, more and more contaminated and substandard drugs are being produced. Because the healthcare and pharmaceutical industries have a direct impact on consumers, federal government agencies must monitor, control, and regulate these industries. Because they can cause direct harm to ordinary people, the government must ensure that these businesses create, manufacture and supply only high quality products. Manufacturers and regulators should ensure that drugs are sterilized to ensure consistent product quality and increase the feasibility and reliability of the drug development process. Therefore, more attention is paid to the creation of a reliable and comprehensive regulatory framework to ensure the high quality of pharmaceutical products. Increasingly, high-level sterilization and disinfection methods are being used. Sterile filters are also gaining popularity over non-sterile filters given their efficiency and superior results compared to alternatives. Increased public and commercial spending on drug discovery and procedures, strategies and methodologies to test the quality and reliability of all drugs will drive market growth.
Sterile filtration is performed to remove heat-sensitive microbes from pharmaceuticals or other items. Some small molecule toxins may still be present in the final product because the technology, filters used and process have not been thoroughly tested and errors may occur. Mistakes may be made by the sterilizer, or they may be congenital. These mistakes can lead to significant losses for the company and hinder the growth of the market.
Opportunity: Increase public and private funding for pharmaceutical research and development.
The covid-19 pandemic has drawn attention to the inadequate state of healthcare systems around the world. Lack of pharmaceutical capacity, drug research and development infrastructure, and supply chain bottlenecks are causing millions of patients to wait longer for diagnosis and treatment, ultimately leading to higher death tolls worldwide. As a result of the pandemic, the healthcare and pharmaceutical industries have undergone major reforms, with increased investment in infrastructure and other federal support. Even as the intensity of the pandemic began to ease, healthcare innovation continued to advance at a rapid pace. Revenues in the pharmaceutical industry also increased thanks to increased investment in R&D and renewed government support. Federal spending is expected to increase in the future. In addition, sterile filtration is increasingly being used in the food and beverage market due to increased research and development. Increased R&D spending requires enhanced regulatory oversight, internal controls, accountability measures, and quality assurance practices such as sterile filtration. With additional R&D, the market will expand and industry participants will benefit from promising market prospects. Expanding public-private or public-private partnerships will also accelerate market expansion.
Over the past few years, there have been many product recalls due to an increase in cases where substandard medicines have harmed end users. These events occur when the integrity of a product is compromised during packaging, transport, or storage due to changing environmental conditions. Maintaining product quality and integrity throughout the manufacturing process and supply chain is the responsibility of manufacturers and regulators who oversee the healthcare and pharmaceutical industries. Market expansion will be hampered by strict and well-defined rules and regulations, backed up by legal safeguards to ensure inspections and quality control. The authorities are given the resources, staff and authority to implement these accountability measures as it is critical. Consequently, market growth will be limited by the stringent regulations imposed by regulators to control the global sterile filtration market.
View full report with table of contents and chart list: https://www.thebrainyinsights.com/report/sterile-filter-market-13337
• 3M• Alfa Laval AB• Cobetter Filtration Equipment Co. Ltd. • Danaher Corporation • GE Healthcare• Merck KGaA• Parker Hannifin Corporation • Porvair Filtration Corp• Sartorius AG• Sterlitech Corporation
• Angioplasty balloons • Capsule filters • Membranes • Bottle-on filtration systems • Benchtop filtration systems • Cartridge filters • Syringe filters • Accessories • Others
• Pharmaceutical companies • Food and beverage companies • Academic institutions • Research laboratories • Biopharmaceutical companies • Contract manufacturing organizations • Contract research organizations • Others
• Full Fill Processes • Buffer Filtration • Cell Culture Media Preparation • Biological Processes • Water Purification • Air Filtration • Others
• Polyethersulfone (PES) • Nylon • Cellulose mixed ethers • Polyvinylidene fluoride (PDVF) • Polytetrafluoroethylene (PTFE) • Cellulose acetate • Others
• North America (USA, Canada, Mexico) • Europe (Germany, France, UK, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, India, Rest of Asia Pacific) • South America ( Brazil and Rest of South America) • Middle East and Africa (UAE, South Africa, Rest of the Middle East and Africa)
The market is analyzed on the basis of value (billion US dollars). All market segments are analyzed on a global, regional and country basis. The study includes an analysis of more than 30 countries in each segment. The report analyzes the drivers, opportunities, constraints and challenges to provide vital insight into the market. The research includes Porter’s Five Forces Model, Attractiveness Analysis, Product Analysis, Supply and Demand Analysis, Competitor Location Grid Analysis, Distribution and Distribution Channel Analysis.
Brainy Insights is a market research company that provides companies with actionable insights through data analytics to improve their business acumen. They have powerful predictive and scoring models to meet customer goals for high quality products in the short term. They offer individual (client) and group reports. Their repository of syndicated reports is diverse across all categories and subcategories across different domains. Their customized solutions can meet the requirements of customers, whether they want to expand or plan to release new products to the global market.
Avinash D., Head of Business Development Phone: +1-315-215-1633 Email: sales@thebrainyinsights.com Website: http://www.thebrainyinsights.com
Post time: Mar-11-2023